[Home ] [Archive]   [ فارسی ]  
:: Main In Press Current Issue All Issues Search register ::
Main Menu
Home::
Journal Information::
Editorial Board::
Articles archive::
For Authors::
For Reviewers::
Editorial Policy::
Registration::
Contact us::
indexing and abstracting::
::
..
Indexing

 

 

 

 

 
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Creative commons

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

..
:: Search published articles ::
Showing 4 results for Irani

Farnaz Ehdaivand, Masoumeh Rostamnejad , Effat Iranijam ,
Volume 4, Issue 4 (Winter 2004)
Abstract

 

Background & Objectives: Hypertension is the most common medical problem in pregnancy, with  an incidence rate of 6-8%. The patients with preeclampsia are exposed to more maternal and fetal  complications. This requires more intensive prenatal cares. The diagnosis in early stages of disease has an important role in decreasing maternal and neonatal mortality and its comsequent complications. This study was an attempt to determine the epidemiological factors and complications of preeclampsia among patients admitted to Alavi hospital, Ardabil.

Methods: This descriptive retrospective study was conducted on 176 women with preeclampsia. The data were collected using a questionnaire and medical records of patients. These data were analyzed using descriptive and inferential statistics.

Results: 75% of the patients had severe preeclampsia and 25% had mild preedampsia. Regarding the predisposing factors, history of preeclampsia was observed in 23.1% of the cases, mother's underlying diseases in 12.5%, twin in 2.3% and hydramnios in 4%. The method of delivery in 62.5% of the cases was cesarean section. 67.6% of preeclamptic patients had maternal and fetal complications (10.2% Maternal and 57.4% fetal). The maternal complications were: abruptio placenta, (44.4%), eclampsia (22.2%) and coma (11.1%). The fetal complications were: IUGR (42.4%), prematurity (39.6%) and  IUFD (9%).

Conclusion: In this study the incidence of severe preeclampsia was higher, which may be due to insufficient prenatal cares and delay in diagnosis. Further studies about the effect of prenatal cares on pregnancy outcomes in preeclamtic women are recommended.


Fereshteh Sharifi Ferdoey , Shiva Irani, Mojghan Zandi, Masoud Soleimani,
Volume 14, Issue 3 (Autumn 2014)
Abstract

  Background & objectives : T he main goal of tissue engineering is regeneration and restoration of damaged tissues and organs, besides being used in medicine . Scaffolds are the main segments for tissue engineering, and plasma surface modification is one of the modern methods used for surface modification on polymer scaffolds. The aim of this study was to evaluate the effect of nano-fibers with different densities on fibroblasts' behavior besides the plasma surface modification.

  Methods : Poly Ɛ-Caprolactone nano-fibers (PCL) were developed by an electro-spinning technique at different collecting times. These nano-fibers were then modified by oxygen plasma. Cellular attachment to the nano-fiber and their morphology were evaluated using scanning electron microscope (SEM) and cellular activities were also studied by 3-[4,5-dimethylthiazol- 2-yl]-2,5 diphenyltetrazolium bromide (MTT). Scaffold biocompatibility test was assessed using inverted microscope.

  Results : Scanning electron microscope images of nano-fibers showed that increase in time of spinning has significantly heighten fiber density, on the other hand plasma surface modification of nano-fibers had significant effects on their respective biocompatibilities. The result of cell culture showed that nano-fiber could support the cellular growth and replication by developing 3-dimensional topography.

  Conclusion : Our results showed that increase in time of spinning and using plasma surface modification of nano-fibers by oxygen plasma would result in providing surface with the highest similarity to the extracellular matrix.


Effat Iranijam, Mohammad Hossein Hosseini, Mohammad Negaresh, Elham Yousefi Ardabili,
Volume 22, Issue 4 (Winter 2023)
Abstract

A severe acute respiratory syndrome caused by coronavirus 2 infection (COVID-19)was identified in December 2019 and caused a massive pandemic that claimed millions of lives worldwide. The Chimpanzee adenovirus vector vaccine is one of the few vaccines against coronavirus disease in 2020. This case report introduces, a patient who developed thrombocytopenia, fever, and lethargy nine days after vaccination with the chimpanzee adenovirus carrier vaccine. The patient was admitted to the hospital and thrombotic thrombocytopenic purpura (TTP) symptoms appeared during hospitalization.

 
Maryam Ekran, Atabak Sedigh-Namin, Effat Iranijam, Shafagh Aliasgarzadeh, Nazli Javaheri, Afshan Sharghi,
Volume 25, Issue 2 (Summer 2025)
Abstract

Background: Thrombocytopenia is a clinical manifestation of coronavirus disease 2019 (COVID-19), potentially leading to bleeding and affecting disease prognosis. This study aimed to compare the prevalence of thrombocytopenia in deceased and recovered COVID-19 patients admitted to the Intensive Care Unit (ICU) of Imam Khomeini Hospital, Ardabil.
Methods: This cross-sectional study was conducted on 458 patients with confirmed COVID-19 admitted to the ICU of Imam Khomeini Hospital from April to September 2021. After applying exclusion criteria, 403 patients (136 recovered and 267 deceased) were analyzed. Demographic, clinical, and laboratory data, including thrombocytopenia severity, were extracted from medical records and analyzed using statistical tests (e.g., Chi-square and logistic regression).
Results: Thrombocytopenia was observed in 18.4% (25 of 136 patients) of recovered patients and 76% (203 of 267 patients) of deceased patients. The mean age of patients with thrombocytopenia was significantly higher in the deceased group (70.27±13.62 years) compared to the recovered group (61.20±15 years) (p=0.001). Heart failure was significantly associated with thrombocytopenia (p=0.038). Patients treated with remdesivir showed higher thrombocytopenia prevalence in the recovered (84%) and deceased (65.2%) groups, but this was not statistically significant.
Conclusion: Older age and heart failure were associated with increased thrombocytopenia in deceased COVID-19 patients. Severe thrombocytopenia was linked to a higher mortality risk.


Page 1 from 1     

مجله دانشگاه علوم پزشکی اردبیل Journal of Ardabil University of Medical Sciences
Persian site map - English site map - Created in 0.06 seconds with 30 queries by YEKTAWEB 4623